THE MCMANUS GROUP for ACHAOGEN
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 1st Quarter - Report (this page) | Apr 20, 2016 | $50,000 | Replaced |
| 1st Quarter - Amendment | Jun 30, 2016 | $50,000 | Yes |
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
General health care coverage and reimbursement; issues related to infectious disease drug development and procurement; legislative and regulatory issues related to biodefense countermeasure development and procurement; Development of policies to advance the antimicrobial research and development environment. Support of H.R.512 - DISARM Act of 2015" language in - H.R.6 - 21st Century Cures Act.; Food and Drug Administration legislative and regulatory issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MCMANUS | — |
| CHASE M THOMAS | — |
| BARRETT THORNHILL | — |
Budget/Appropriations BUD
Education and advocacy regarding continued appropriations for antibacterial funding initiatives.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BARRETT THORNHILL | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.